Menu Search
Equities

Astrana Health Inc

3AM:MUN

Astrana Health Inc

Actions
  • Price (EUR)40.40
  • Today's Change0.20 / 0.50%
  • Shares traded0.00
  • 1 Year change+32.03%
  • Beta--
Data delayed at least 15 minutes, as of Nov 25 2024 07:01 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Astrana Health, Inc. is a healthcare company. The Company provides care coordination services to each constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The Company's Care Enablement segment is an integrated, end-to-end clinical and administrative platform, powered by its technology suite, which provides operational, clinical, financial, technology, management, and strategic services. Its Care Partners segment is focused on building and managing provider networks by partnering with provider partners for coordinated care delivery. Its Care Delivery segment is a data-driven care delivery organization focused on delivering accessible care to all patients. Its care delivery organization includes primary care, multi-specialty care, and ancillary care services.

  • Revenue in USD (TTM)1.72bn
  • Net income in USD62.46m
  • Incorporated2008
  • Employees1.80k
  • Location
    Astrana Health Inc1668 S. Garfield Avenue, 2Nd FloorALHAMBRA 91801United StatesUSA
  • Phone+1 (626) 282-0288
  • Fax+1 (818) 839-5190
  • Websitehttps://www.astranahealth.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		ASTH:NAQ since
announced		Transaction
value
Prospect Medical Holdings Inc-Managed Care BusinessAnnounced08 Nov 202408 Nov 2024Announced-28.26%745.00m
Data delayed at least 15 minutes, as of Nov 25 2024 20:59 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.